BioForce Nanosciences (BFNH) Short Interest Ratio & Short Volume

Short interest is the volume of BioForce Nanosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 500 shares of BFNH short. 0.00% of BioForce Nanosciences' shares are currently sold short. Learn More on BioForce Nanosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BFNH shares currently have a short interest ratio of 1.0. Learn More on BioForce Nanosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of BioForce Nanosciences' floating shares are currently sold short.

BioForce Nanosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 500 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of BioForce Nanosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to BioForce Nanosciences: Owlet, Inc. (3.82%), Prenetics Global Limited (0.34%), Akoya Biosciences, Inc. (10.28%), Syntec Optics Holdings, Inc. (0.38%), Singular Genomics Systems, Inc. (2.91%), Know Labs, Inc. (3.05%), Optex Systems Holdings, Inc (0.24%), ClearSign Technologies Co. (0.52%), MultiSensor AI Holdings, Inc. (1.77%), International Isotopes Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Strategy Incorporated ($10.45 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), Apollo Global Management, Inc. ($3.83 billion), The Kroger Co. ($2.56 billion), Hims & Hers Health, Inc. ($2.06 billion), Dell Technologies Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.90 billion), Amcor plc ($1.76 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

Short selling BFNH is an investing strategy that aims to generate trading profit from BioForce Nanosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioForce Nanosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BFNH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BFNH, twice per month. The most recent reporting period available is April, 30 2025.